Explorer les evidences

19,3 %19.3% of the respondents had provided money for breast cancer screening.

Nigeriacancer du seinobservé 2018publié 2023PloS onePubMeddocument de 14 observations

1,22 odds_ratioA novel breast cancer risk variant in region 10p15.1 has an odds ratio of 1.22 with a 95% confidence interval of 1.08–1.38 and a p-value of 0.0015 in women of African ancestry.

Nigeriacancer du seinpublié 2013Carcinogenesiseurope_pmcdocument de 4 observations

1,65 hazard_ratioTravel time ≥30 minutes was associated with an increased risk of death (hazard ratio, 1.65).

Nigeriacancer du seinobservé May 2009–January 2019publié 2021CancerPubMeddocument de 7 observations

Serum leptin, total cholesterol, triglycerides, and LDL levels were higher (p < 0.05) in the breast cancer patients relative to control subjects.

Nigeriacancer du seinpublié 2025Breast cancer (Tokyo, Japan)PubMeddocument de 8 observations

39 participantsThirty-nine out of 46 participants (85%) knew that a breast lump was a possible sign of breast cancer.

Nigeriacancer du seinpublié 2025BMC cancerPubMeddocument de 11 observations

33 participantsThirty-three out of 46 participants (72%) lacked knowledge of early symptoms and signs of breast cancer.

Nigeriacancer du seinpublié 2025BMC cancerPubMeddocument de 11 observations

23,4 odds_ratioOdds ratio for BRCA1 was 23.4 (95% CI, 7.4 to 73.9).

Nigeriacancer du seinpublié 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 14 observations

12,2 %Ten (12.2%) of the 82 breast cancer patients presented early.

Nigeriacancer du seinobservé 2011–2015publié 2020The Pan African medical journalPubMeddocument de 16 observations

59,2 scoreThe pre-intervention overall functional quality of life domain score was 59.2 ± 21.98 for the intervention group.

Nigeriacancer du seinpublié 2021Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 8 observations

72 %Among 607 patients diagnosed with breast cancer in Nigeria between January 2010 and December 2018, 72% received chemotherapy.

Nigeriacancer du seinobservé 2010–2018publié 2021International journal of cancerPubMeddocument de 12 observations

23,2 %Nineteen (23.2%) of the breast cancer patients were seen during the second year of follow-up.

Nigeriacancer du seinobservé 2011–2015publié 2020The Pan African medical journalPubMeddocument de 16 observations

79,52 %264 (79.52%) of the respondents performed breast self-examination (BSE).

Nigeriacancer du seinpublié 2020West African journal of medicinePubMeddocument de 6 observations

0 p_valueRare germline mutations in MTCL1 were significantly associated with a higher contribution of the APOBEC C>T signature (p = 6.1 × 10⁻⁶).

Nigeriacancer du seinpublié 2019International journal of cancereurope_pmcdocument de 4 observations

25 %Breast cancer is the most prevalent cancer for women in Nigeria, representing 25% of all cancers in women.

Nigeriacancer du seinpublié 2024Cancer reports (Hoboken, N.J.)PubMed

26,6 kg/m2Post-menopausal women with breast cancer had significantly higher BMI (26.60 ± 5.17 kg/m²) compared to controls (22.73 ± 1.21 kg/m²), with P < 0.001.

Nigeriacancer du seinpublié 2021Nigerian journal of clinical practicePubMeddocument de 6 observations

29 %Chemotherapy contributed 29% of the total costs for breast cancer care.

Nigeriacancer du seinpublié 2025American journal of surgeryPubMeddocument de 13 observations

7 %Among all cases, 7.0% carried a loss-of-function mutation in BRCA1.

Nigeriacancer du seinpublié 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 14 observations

Nigeria reports the highest age-standardized mortality rate for breast cancer among African countries.

Nigeriacancer du seinpublié 2021Annals of global healthPubMeddocument de 7 observations

18 %Immunotherapy contributed 18% of the total costs for breast cancer care.

Nigeriacancer du seinpublié 2025American journal of surgeryPubMeddocument de 13 observations

11,4 %Only 11.4 percent of study participants had good knowledge of breast cancer.

Nigeriacancer du seinpublié 2023African health sciencesPubMeddocument de 4 observations

0,002 p_valuePALB2 was significantly associated with breast cancer (11 cases, zero controls; P = .002).

Nigeriacancer du seinpublié 2018Journal of clinical oncology : official journal of the American Society of Clinical Oncoloeurope_pmcdocument de 14 observations

Many participants described the breast cancer treatment experience as unpleasant and painful, with side effects including nausea, insomnia, sore throat, and hair loss.

Nigeriacancer du seinpublié 2023African journal of reproductive healthPubMeddocument de 4 observations

13,06 scorePost-intervention mean BSE practice scores in the traditional method group increased to 13.06 ± 2.74.

Nigeriacancer du seinpublié 2024BMC cancerPubMeddocument de 11 observations

APTT was significantly shorter in breast cancer patients than in healthy controls.

Nigeriacancer du seinpublié 2021Cancer investigationPubMeddocument de 4 observations

0,64 AORWomen in the uppermost category of occupational physical activity had an adjusted odds ratio of 0.64 for breast cancer risk.

Nigeriacancer du seinpublié 2022Cancer epidemiologyPubMeddocument de 6 observations